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Abstract
This chapter will be an ethical analysis on challenging situations surrounding 
oocyte cryopreservation treatment in young healthy women. There has been always 
a complicated interaction between technology and changing societal values. This 
ethical discussion is not on whether or not oocyte cryopreservation in itself is ethi-
cally justifiable. Through a comprehensive literature review, this chapter discusses 
some ethical aspects that have emerged since oocyte cryopreservation was applied 
for the first time. Through a practical approach, this chapter address ethical uncer-
tainties presenting case studies, ethical questions and terms, existing arguments 
in favor and against oocyte cryopreservation; and examine the individual patient’s 
beliefs, perception and opinions.
Keywords: Egg freezing, Oocyte cryopreservation, Non-medical reason, 
Reproductive technology, Ethics
1. Introduction
Fertility preservation is a recent technology that provides the possibility to 
maintain reproductive ability to women who either face the risk of infertility for 
medical treatments or want to postpone childbearing for possible age-related fertility. 
The majority of users of Fertility Preservation technology are women who for cancer 
therapies receive chemo and radiotherapy that can cause infertility [1–3]. However, 
there are more conditions that required medical treatment can damage reproductive 
cells such as autoimmune diseases and myelodysplastic syndromes. Women affected 
by X trisomy, X-fragile, premature ovarian failure (POF) based on genetic origin 
as in Turner syndrome mosaicism, and syndrome, are another group that fertility 
preservation could help them [4]. Finally, the last group of women who can benefit 
from fertility preservation are those who wish to preserve and store oocytes for non-
medical purposes. This procedure is called with various names such as elective egg 
freezing; social egg freezing, and planned oocyte cryopreservation also known as OC.
The first successful result of OC technique was a baby has born from a previ-
ously frozen oocyte in 1896, in the US [5]. Until 2012 OC has been classified 
as experimental by the ASRM but after a review of the scientific literature the 
Committee announced that the success rate of in vitro fertilization (IVF) using 
fresh eggs and frozen eggs are positively similar, so that they removed the experi-
mental label from OC treatment. In addition, the existent studies about the health 
of babies born from frozen eggs did not prove a remarkable congenital anomalies 
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raise when compared with other IVF babies [5]. However, while the ESHRE, ASRM 
and Ethics Committee approved the use of OC for Medical reasons (mostly patients 
affected by cancer therapies) [5, 6]. they declined the use of OC for healthy women 
who wish to avoid age related fertility decline for postpone the maternity (for social 
reasons). In spite of not being recommended OC for non-medical reasons because 
of insufficient data on “safety, efficacy, ethics, emotional risks, and cost-effective-
ness” the number of women seeking OC for social reason as well as the numbers of 
clinics offering OC technique have been increasing [7–9].
One year after removing the experimental label from OC, ASRM published 
an article in their website in which they explained about how healthy women can 
benefit from OC technique to postpone childbearing [10]. This article declared that 
although this new medical technique is improving, it raises “ethical issues involving 
evaluation of evidence, balancing benefits and harms, supporting patient auton-
omy, avoiding conflict of interest, and promoting advances in health care” [10].
This chapter addresses the ethical issues that arise when OC is used by women 
whose goal is to protect their ability to have children in the future apart from 
an immediate threat from gonadotoxic therapy. This ethical discussion is not on 
whether or not oocyte cryopreservation in itself is ethically justifiable. Through a 
comprehensive literature review, this chapter argues some ethical uncertainties, 
ethical questions and terms, existing arguments in favor and against oocyte cryo-
preservation; and examine the individual patient’s beliefs, perception and opinions.
2. Ethical uncertainties
The OC technology improvement itself was not the only reason for women’s 
interest to postpone childbearing. In many countries, the number of women who 
defer childbearing to their thirties has been rising [11]. For decades, women have 
been having children at older ages due to substantial lifestyle changes worldwide. 
By 1970, the average age of the first childbirth increased to around thirty years old, 
which at that time was the last chance to try for motherhood. With increasing knowl-
edge about women’s reproduction and fertility, since 1980 more women started to 
have children at 40–45 years old [12, 13]. Among all the reasons that affected this 
social change, access to education and increasing participation at workplace were 
the most significant. Since for women the age range (20s and 30s) in which they can 
peruse their education and improve their social position is also the same period of 
being optimal fertile (20s and early 30s) and starting to weakening at late 30s [14].
Terms such as “postponing the maternity” or “delay childbearing” are often used, 
which refers to the idea that the most important women’s duty “motherhood” is at 
risk and if they do not accomplish this responsibility they are blamed to be selfish 
and irresponsible [15]. While studies show that, many women face conflicts in their 
life because the optimal moment for educational and professional improvement 
coincides exactly with when their reproductive system is in its best condition. Other 
issues such as partnership and economic situation has been also reported as other 
barriers on women’s path for childbearing at younger age. Many women who wanted 
to have children find themselves in an inacceptable economic condition or not having 
an adequate partner [16–19]. Finally, what seems like a delay might be a consequence 
of the extensive and continuous overestimation of female reproductive potential 
with age and the capacity of reproductive treatments to recover the potential [20].
Given these societal and personal reasons for late reproduction, a biological 
treatment emerges because the older women are the higher risk of failure to con-
ceive as both the quantity and quality of the oocytes decreases, while chromosomal 
abnormalities causing fetal abnormalities increases. Men’s age also affects fertility 
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and offspring health, although not until men are older, age 40 or 50. For both men 
and women, the more time passes before they reproduce, the risk of some disorders, 
life circumstance, or accident may affect their fertility or abnormality in offspring.
Traditionally women, who wish to become a mother at younger ages, had the 
possibility to undergo IVF with donor oocytes, when they face oocyte quality problem 
or other diseases. Planned OC offers a further option for women in this condition, if 
they have previously stored their own oocytes, might help them to become mother. 
Compared with using donor oocytes, planned OC provides benefits such as genetically 
related with the off spring. Although planned OC ultimately will be ineffective in some 
percentage of cases, it will allow some women and couples who otherwise would have 
had to forego biological parenthood the chance to have genetically related children.
With this background, let us consider some of the ethical arguments in favor 
and against oocyte cryopreservation. A wide range of viewpoints on planned OC 
have been presented by researchers and commentators [21–27], while several com-
mentators raise questions and concerns about planned OC, most conclude it should 
be available to women who are fully informed and wish to use it [24, 26].
2.1 Arguments supporting oocyte cryopreservation by healthy women
In 2012, the European Culture of Human Multiplication and Embryology 
(ESHRE) validated a plan to safeguard the richness of arranged OC [28]. The main 
advantage of planned OC is that it provides reproductive autonomy, by giving 
women greater number of reproductive options. There are several contributors 
to this argument. First, by giving women time to flourish in their education and 
careers, planned OC reduces the pressure of the ‘ticking biological clock’ and the 
pressure of having a child when the woman is not yet financially, emotionally, or 
situationally ready [17, 29–31]. Although all these factors are obvious benefits, recent 
research suggests that the lack of a partner is one of the main reasons a woman 
preserves her oocytes compared to other reasons [27, 32]. While oocyte freezing at 
a younger age gives the best chance to preserve oocyte quality, critics argue that an 
overreliance on genetic parenthood using this method might negatively impact and 
even stigmatize parents from pursuing other, more traditional options [15, 33].
The second strong argument for promoting planned OC is to give more control 
to women with regards to their preserved gametes compared to frozen embryos. In 
the case of embryos, which already has genes from the egg and the sperm, a divorce 
or separation could result in a partner retracting consent. This leads to additional 
difficulties on the clinical, emotional and legal front, which can be avoided by 
freezing individual gametes.
Thirdly, oocyte freezing is a more acceptable option for those who are not 
comfortable with preserving embryos due to moral and religious reasons [27, 34]. 
Indeed, some theologists trust ovarian cryopreservation and subsequent autologous 
transplantation later in life as morally acceptable because it does not rely on IVF 
for procreation [35]. Furthermore, women are allowed a possibility of having a 
genetically related child even if they do not have a partner when the oocytes are 
preserved. Hence, even though embryo cryopreservation is the more established 
procedure, women prefer oocyte preservation because of the independence it gives 
them from their partner [36].
It is to be noted that oocyte cryopreservation in this context is not performed 
in response to the onset of disease; rather, it is meant as protection against future 
infertility. The benefits of oocyte conservation by women are comparable to the 
cryopreservation of sperm by men, however, the costs, physical demands and the 
risks of the two procedures are completely different. Nevertheless, men face far less 
criticism when trying to preserve their future fertility compared to women [19].
Infertility and Assisted Reproduction
4
A few authors note that planned OC may increase social justice by removing 
the obstacles that women face when planning for a family due to their shorter 
reproductive windows. Planned OC can minimize the burden of career and educa-
tion that women face in their most fertile period and can extend their reproductive 
timeframe. Although this could significantly contribute to equality between men 
and women, this is currently not the case because of low uptake of the process in 
certain populations [19, 21, 28]. It is possible to postulate that women would feel 
and act equal to men if given the choice to extend their reproductive age. This could 
eventually mean women becoming mothers at 50 or 60 years of age, while currently 
they face biological constraints around the age of 40 [37].
Critics argue that advanced maternal age could be detrimental to children as 
older parents could have lesser energy to look after young children and might die 
before the children grow into young adults [31, 38]. However, preliminary data 
shows that most women actually plan on using their frozen oocytes in their 40s, and 
would rarely consider becoming parents in their 50s or 60s, mainly because of the 
higher risks to health that women face in advanced maternal age [30].
Interestingly, women who do become parents at an advanced age report that 
they have less pressures of establishing a career and more financial freedom, which 
gives them more time to focus on their family and enjoy parenthood [39]. Indeed, 
there is no conclusive evidence to show that younger mothers are better mothers, 
and more empirical data collected through longitudinal studies on children will help 
answer this. Nevertheless, a strong argument against older mothers is that women 
play important roles as grandmothers, and advanced maternal age would prevent 
children from enjoying social contact with their grandparents [38].
2.2 Arguments opposing oocyte cryopreservation by healthy women
A major hurdle in the advancement of routine oocyte cryopreservation is its 
safety [40], in addition to potential repercussions for future children and for 
mothers who choose pregnancy at older age. Several precautions should be taken, as 
there is a high level of uncertainty, with extra discretion applied when cryopreserv-
ing oocytes. There is currently not much data surrounding the harm to the health 
of children born from frozen oocytes, however; early reports suggest that these 
children do not have adverse health outcomes compared to children born without 
these interventions [41, 42].
Indeed, the Ethics Committee of the American Society for Reproductive 
Medicine lays out several arguments that planned OC is potentially safer than OC 
before gonadotoxic therapy in response to disease, because the patient is not already 
suffering from a serious disease nor are they delaying treatment due to fertility 
concerns [19]. Interestingly, ovarian hyperstimulation syndrome, the most common 
risk of OC, is actually decreased when the OC is planned because there is no embryo 
transfer once the stimulation cycle is finished. Additionally, it has been shown that 
the use of gonadotropin-releasing hormone agonist triggers can lead to a further 
reduction in the risk of ovarian hyperstimulation when they are used with gonado-
tropin releasing hormone antagonist cycles [43].
The committee hypothesizes that data on the long-term safety and efficacy of 
planned OC is not widely available because of the time involved in patients return-
ing to use their cryopreserved oocytes and in the time it takes for the children 
derived from those oocytes to grow up. Additionally, the process of vitrification for 
easy cryopreservation was only recently adopted.
Another strong argument against the use of OC is the ‘false hope’ that the pro-
cedure might offer to women who are planning their future children [40]. Although 
the technique is undergoing significant advancements, live birth rates with 
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cryopreserved oocytes are still low and this is difficult to predict before a pregnancy 
progresses. This, in addition to the fact that OC does not guarantee success for a 
future pregnancy, poses a significant risk for waste of resources both in terms of 
time and money [27, 44]. The emotional wellbeing of a woman is also under threat 
when she relies on this technique for her reproductive goals.
In all, the committee strongly believes that a woman must make an individual 
choice when it comes to using planned OC after assessing the risks involved and the 
benefits derived from the procedure. This ‘false security blanket’ issue is especially 
relevant when planned OC is thought of as an ‘insurance policy’ for women who 
want to bear children in the future, which can pose problems when women develop 
an overreliance on this technique for their reproductive goals. However, the concern 
of overreliance assumes without prior evidence that women will dismiss other 
available options such as reproduction or immediate marriage, just because of 
cryopreserving oocytes [15].
Education and informed consent are the best ways to address patient misun-
derstanding of the success rates of planned oocyte cryopreservation. Towards this, 
physicians and other healthcare professionals involved in the process must observe 
restraint when describing the technique to avoid giving false hope. However, when 
there is a risk of overreliance on any one method of conception, it is common for 
patients to struggle in their decision-making process. It is important to present 
appropriate medical counseling to these patients and it is imperative for the health-
care provider to place trust in the patients’ capability to make an informed decision 
when all information is duly presented. Essentially, patient choice should not be 
removed because of physician bias in underestimating their capabilities. More 
research into this topic will be crucial to address these biases.
Current research is looking to address questions about the number of oocytes, 
classified by age and hormone levels, that are needed to have a higher chance of a 
successful pregnancy using those oocytes [45–47]. It is important that this data is 
relayed to patients. For instance, if a woman knows that when is 38 years old she 
needs to store 25–30 oocytes in order to stand a chance of having one child, she is 
better informed and not falsely over reliant on the procedure [47–49].
Another downside of planned OC are its costs, which are usually paid out-of-
pocket by women, with multiple cycles adding to the expense even more [45]. As 
discussed previously, OC is sometimes the only option for women who undergo 
social freezing, and for couples who cannot undergo embryo freezing due to 
ethical and/or religious beliefs. There are also countries where embryo freezing is 
prohibited through legislation. Even though embryo freezing is typically covered 
by insurance providers, this is not the case for elective oocyte freezing. This is 
partly fuelled by the position of the ASRM, which still does not encourage oocyte 
cryopreservation for personal elective reasons but promotes OC for cancer and 
other medical indications by removing the term ‘experimental procedure’ from its 
recommendations [50].
In most of the western world, especially in Europe and the United States, the 
cost of a single cycle of egg freezing is between $10 000–15 000. Understandably, 
the procedure has faced a lot of criticism regarding the cost-effectiveness of the 
technique. Indeed, the costs are not only limited to the retrieval and storage of 
oocytes. After the patient decides to use the frozen oocytes, IVF needs to be used 
to promote embryo formation. Recent research suggests that direct IVF concep-
tion at the age of 40 years is more-cost effective when compared to cryopreserv-
ing oocytes at 35 years followed by IVF at 40 years [51, 52]. In contrast, another 
study that developed a cost-effectiveness algorithm shows that the highest cost–
benefit is obtained when the oocytes are cryopreserved when women are 37 years 
of age [53].
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Recent findings also suggest that only 10% of women who opted for planned 
OC for social reasons came back to use them for a pregnancy [54]. This indicates 
that the associated costs are not being realized in most cases. Elective oocyte 
banking does not come with the financial advantages of oocyte freezing for medi-
cal purposes, which are often discounted through compassionate donations from 
specialized pharmacies or are supported through organizations raising funds for 
cancer patients. Additionally, many countries do not recognize the right of a woman 
to reproduce through this method and view OC as an elective procedure similar 
to plastic surgery for cosmetic purposes rather than a medical necessity. The high 
costs associated with OC and IVF and these social restrictions contribute to women 
missing chances to safeguard their future fertility.
Although some large companies have started offering planned OC as a health 
benefit [55], they are still very few to make a difference in a majority of women’s 
lives. Planned OC is likely an option only for a small percentage of women, which 
would result in the benefits of education, career and life-stability available only to 
these privileged women. Indeed, there are concerns raised about the inequitable 
societal consequences of planned OC.
The committee also discusses a related issue in its opinion on OC before gonado-
toxic therapy – and suggested that a person cannot be denied having an offspring 
because of their potentially shortened lifespan because of disease. However, this 
does not mean women can carry pregnancies without concerns about maternal age. 
Several studies show that the mother and baby are at increased risk with an increase 
in the age of the pregnant woman [56–58].
Moreover, children may undergo psycho-social trauma as a result of having an 
older mother compared to traditional reproductive options [38, 44]. Women should 
be made aware of these risks when they consider cryopreserving their oocytes [59].
Next, it is important to hypothesize the social implications of planned OC 
if it were to become mainstream. Although generally thought of as increasing 
women’s choices and giving reproductive freedom, it could reduce their repro-
ductive autonomy by not giving importance to the social structures surrounding 
female biology [33, 38, 40]. Moreover, there is a risk of social expectations shifting 
to pressure women into freezing their eggs if they want to have biologically or 
genetically related children while pursuing a successful career [34]. Taken these 
into account, what first appeared as a way of empowering women to take control 
of their reproductive choices by giving them the freedom to pursue their dreams 
without the constraints of a biological clock could turn into a tool that unknowingly 
oppresses them [33]. This future would see women having less of a choice in their 
reproductive journeys, and would be socially compelled to become a parent later in 
life because they have the choice to do so, and in the worst case, would be expected 
to refrain from parenthood completely [34]. Although this seems extreme, societal 
structures have evolved around oppressing women before and this can happen 
again. For planned OC to work successfully, measures need to be in place to ensure 
that the reproductive autonomy of women is maintained while achieving equality, 
without relying on “medicalization”, which is a tendency to seek medical answers to 
social problems [28].
Therefore, as noted by several ethicists, an important question to answer is 
‘who should be qualified to offer these services’? [60]. The amount of time, money, 
expectations and emotions that social freezing patients involved in the cryopreser-
vation of gametes go through must be taken into consideration. Achievable stan-
dards need to be in place to guide organizations offering cryopreservation and those 
advertising such services. Indeed, OC has been marketed to healthy women for a 
few years, even though there are safety and efficacy concerns surrounding it [61]. 
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Studies from Spain and USA report that many clinics fail to sufficiently educate 
clients for them to make a well-informed decision [61, 62].
Another concern raised with respect to planned OS is the uncertain ownership 
of the gamete. Human eggs have become widely sought-after in the assisted repro-
duction of infertile women, which has led to a market of women selling their own 
eggs to egg banks for money [63]. This system could exploit young women who are 
looking for ways to make money.
A related concern with planned OC and ownership relates to the disposition of 
gametes in the case of an accidental death or when the donor succumbs to a disease. 
An important question that should be addressed with patients is how the oocytes 
should be disposed of in case the biological owner dies. Although this issue is raised 
with patients that are undergoing fertility preservation for medical reasons such as 
cancer therapy, this should also be an important topic of discussion with patients 
that are preserving their oocytes for reasons that are not medical.
Additionally, ownership must also be made clear in cases where donors become 
ill or impaired cognitively that raises concerns over assisting them in their repro-
ductive goals. Moreover, some women may not agree to policies that govern their 
ability to give their cryopreserved eggs to third parties or to donate it to research 
and teaching. Another point of interest is that ASRM does not support the use of 
frozen gametes for the donor’s relatives if the donor dies, even if biological owner 
specially requests it [46]. This is, however, possible in some countries. Details of 
cryopreservation such as how long the frozen eggs can be used, and who uses these 
eggs need to be discussed at the time of consent; this also requires specific policies 
adopted by clinics and legislation.
Finally, a major hurdle facing OC, especially for patients cured by cancer is the 
morality of a child born to a mother who has a deadly disease. This can be catego-
rized into four major concerns: shorter lifespan of the mother, a recurrence of the 
cancer or other medical conditions that will be detrimental to the mother’s health, 
the health of children born to women who froze their oocytes after starting gonado-
toxic treatment, and a genetic disposition of cancer from the mother carrying 
over to the child. Eventually, provisions must be made for parenting and financial 
responsibilities in case a single woman uses her cryopreserved oocytes at an older 
age or after treatment for a fatal disease.
3. Individual patient’s beliefs, perception and opinions
The concept of freezing eggs as a potential method of preserving fertility has 
been analyzed from various viewpoints and social science disciplines. The profile 
of patients who would use this technology and their reasoning behind using it are 
all being explored [64–67], As shown previously, most women who want to freeze 
their eggs are single and already have a decline in their fertility and the amount of 
eggs [67]. They choose to freeze their eggs because of a variety of reasons, impor-
tant among them the physical, economical, structural, and personal factors. Indeed, 
it was found that women chose to freeze eggs because of the absence of conditions 
crucial for pursuing motherhood, and not because of the presence of any dominant 
reasons [68]. Interestingly, there have been investigations into fertility preserva-
tion and the attitudes surrounding it in several countries [69–74]. The majority of 
studies point towards an increasing acceptance of these technology which correlates 
with an increase in knowledge about them [70, 72].
These studies indeed provide necessary insights into the attitudes of women 
towards specific aspects of the freezing process especially from medical and 
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social viewpoints. Three major viewpoints of women regarding egg freezing is 
detailed below.
Owner of their life: This group of people identify women as being responsible 
for their own reproductive life, and is often associated with being a viewpoint 
that emphasizes an individual’s choice without disturbances from outside factors. 
Although the right to reproduction is of utmost importance to these women, they 
are generally indifferent towards policies that intervene to facilitate being children 
at a younger age. This viewpoint assumes that egg freezing is a potential option for 
claiming their right to having a child.
Policy change requester: In this group of people, the predominant viewpoint is 
that assistant reproduction with technology is often unwarranted, especially for 
reasons that are not medical. It emphasizes on policies being enacted to ensure the 
wok-life balance of women. This viewpoint perceives policy chance as the only 
successful way of improving the conditions necessary to facilitate having a child 
and bringing them up.
Need for social information: This group of people need a debate on a societal 
scale. This point of view approves the use of egg freezing for both medical and 
non-medical purposes. The viewpoint encourages social debate to understand these 
questions in more detail and do not support the idea of a ‘right’ to have a child in 
this context. This viewpoint hence associates OC as a legitimate and responsible 
option to support socio-cultural changes and is not supportive of unnecessary 
regulatory intervention.
This final section details the challenges that assistive reproductive technologies 
face in the context of what is the traditional path to pursuing life and parenthood. 
For instance, women do not have access to infertility care or options for assistive 
reproductive technologies in several European countries [75].
Certainly, another important example is the utilization of parental leave. It is 
well established that men generally under-utilize parental leave while women take 
longer leaves of absence from work to care for young children. This also translates 
into more women with children switching to part-time work in order to facilitate 
the careers of men [76]. Although these balances and imbalances in family and 
career are acknowledged in all the viewpoints discussed above, it is perceived dif-
ferently in all of them.
Viewpoint one focused on individual and autonomous choices with regards 
to fertility and did not care to venture into understanding policy interventions. 
Alternatively, viewpoint two was strongly in favor of restrictions placed on repro-
ductive technologies with a preference for changing policies to facilitate good 
work-life balance. Finally, viewpoint three promoted social debate with respect 
to egg freezing, while disapproving regulatory interventions regarding the same. 
These varying viewpoints on who is responsible for their choices and how it should 
be regulated reflects on ideas of autonomy and maternalistic tendencies.
Indeed, the current standing of the authorities on the subject through a litera-
ture review suggests that it is important for a physician to prioritize autonomous 
choices compared to maternalistic tendencies [28]. However, it is important to note 
that viewpoints that favor these maternalistic attitudes often prevail.
Interestingly, there are several different perspectives on how egg freezing and 
gender equality are related. These different viewpoints suggest that freezing of eggs 
can be used a tool to eradicate gender inequality and the discrimination that women 
face. In fact, viewpoint three perceives egg freezing as a responsible choice keeping 
in line with changes in the socio-cultural landscape. This correlates well with the 
thoughts of Carroll [66], who framed this as “enacting responsible reproductive 
citizenship”. However, despite these positive changes that egg freezing can be 
responsible for, it is imperative to not view it is as the solution for social injustices 
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to women [31]. Understandably, it is important to not restrict access to egg freezing 
based on these debates; however, it is imperative that legislation and employers 
attempt to address the real reasons behind the need for delayed childbearing for 
working mothers [28].
Certainly, the literature suggests that it is the diversity of viewpoints surround-
ing egg freezing that is responsible for controversies compared to the technology 
of egg freezing itself. Women who decide to freeze their eggs not only deal with all 
the ethical issues surrounding this technology, but also have to deal with changing 
opinions and viewpoints on this practice in their daily life. Some of these include 
being pressured to freeze their eggs to be a “responsible citizen”, an unrealistic 
understanding of the success rates of such procedures, and the stigma they face 
when faced with stereotypes in their environment [15, 77].
Therefore, it is important to understand that while egg freezing certainly holds 
benefits for women by relieving them from the pressure of the biological clock, it 
could be harmful in other ways by psychologically impacting their experience based 
on societal expectations [78]. These points need to be considered together when dis-
cussing egg freezing. It is also crucial to understand not only the opinion of women 
but also that of men and other groups of people who might contribute to further 
controversies in the decision-making process of a woman.
4. Discussion and conclusion
Several challenges that assistive reproductive technologies face stems from cer-
tain misconceptions regarding their use and a lack of understanding the power and 
limitation of these technologies. Adding to these challenges are dishonest marketing 
campaigns overestimating the success of these procedures, a difference in success 
rates in different clinics and a misunderstanding of the process involved in the 
procedures. There is an imminent need for oversight and regulation of this technol-
ogy and marketing because enthusiastic entrepreneurs target women at cocktail 
parties and other informal events to convince them to “freeze their eggs” before it’s 
too late, suggesting that “smart women freeze” and the others miss out. These state-
ments and marketing strategies are ethically and morally unacceptable, especially 
when women are not provided the complete picture with regards to the costs, time 
and risks involved and the low success rates of the procedure which is typically not 
covered by insurance. Information such as the number of cycles to freeze enough 
eggs, the cost involved in each cycle of cryopreservation, including the medications 
and time involved, the cost of storage of eggs per year, the age-related decrease in 
success rates of the procedure, the cost of the use of future eggs with intracyto-
plasmic injection of the sperm, the risk to the women of ovarian hyperstimulation 
syndrome occurring as a result of ovarian stimulation and the side effects, and more 
importantly the chance that there will be no baby at the end of the risky procedure 
should all be communicated to the patient in clear terms to facilitate them making 
an informed decision. These discussions should also involve the fate of the gametes 
in case of death, disease, disability or if the donor decides to not personally use the 
gametes. Patients that are already confused with the options available to them will 
need to be guided into the system by developing trust and by portraying transpar-
ency through standardization of care. Otherwise, there is a risk that they will be 
further confused by the deluge of information available and might withdraw from 
options available to them. Finally, there is an urgent need for a change in the cur-
riculum when training OB/GYN residents and primary care physicians to include 
information about fertility decline and the options available to couples and women. 
To eventually promote successful reproductive decision making in patients and to 
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